SCHEMBL19082211

SCHEMBL19082211

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5sc6c(ccc7sc8c9ccccc9ccc8c76)c5c4)cc3)c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.44
CYP1B1 Q16678 5/20 0.44
LIMK1 P53667 2/20 0.40
F9 P00740 2/20 0.38
CYP1A2 P05177 4/20 0.38
PIM3 Q86V86 2/20 0.36
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
ROCK1 Q13464 1/20 0.34
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HSD17B1 P14061 1/20 0.33
CYP2B6 P20813 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082139 0.97 CYP1A1 (0.44) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL19082089 0.96 CYP1A1 (0.45) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL17944821 0.96 CYP1A1 (0.47) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL17247141 0.93 CYP1A1 (0.47) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL19082212 0.92 CYP1A1 (0.44) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL19082213 0.92 LIMK1 (0.40) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL17247167 0.92 CYP1A1 (0.47) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL17246873 0.92 CYP1A1 (0.48) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL17247147 0.91 CYP1A1 (0.48) CYP1A1CYP1B1LIMK1F9CYP1A2
SCHEMBL17246872 0.91 CYP1A1 (0.48) CYP1A1CYP1B1LIMK1F9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885LIMK1 440/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885LIMK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.